Prevention * Can ELEOTIN® prevent hyperglycemia?
ELEOTIN® was shown to prevent hyperglycemia in animal experiments at the Julia MacFarlene Diabetes Research Centre at the University of Calgary. This is how the tests were conducted: Two rat groups were used. The rat type used had a strong predisposition to becoming hyperglycemic over time. That is, if the rats were left untreated they all would develop high blood glucose levels. The results indicated after ten weeks only 10% of the ELEOTIN® rat group was considered hyperglycemic whereas 70% of the control group that was given a placebo saline drink were hypoglycemic. The average blood glucose levels after ten weeks was 168 mg/dl (9.3 mmol/L) for the ELEOTIN® group compared with 354 mg/dl (19.7 mmol/L). Based on this test and other similar animal tests, we can say that ELEOTIN® provides a very high degree of preventive assistance. Background Insulin receptor upregulation increases insulin binding and the absorption of glucose into cells. Beta cell regeneration in the pancreas creates i
